From surgical transplants to next-generation regenerative biologics — a complete, evidence-based guide to every method available in 2026.
Follicular Unit Extraction is the gold standard of surgical hair restoration. Individual follicular units — each containing 1–4 hairs — are extracted from the donor area (typically the back of the scalp) using a micro-punch device, then implanted into thinning or bald areas with precision.
FUE accounts for over 92% of hair transplant procedures performed in the United States as of 2025, favored for leaving no linear scar, allowing shorter recovery times, and producing highly natural results when performed by an experienced surgeon.
Follicular Unit Transplantation — known as the "strip method" — involves removing a thin strip of skin from the donor area, dissecting it into individual follicular grafts under a microscope, and implanting those grafts into the recipient sites. It remains a viable option for large-session procedures requiring 4,000+ grafts.
FUT typically yields a higher graft count per session and is more cost-efficient for extensive hair loss, though it leaves a linear scar that requires longer hair to conceal.
DHI uses a specialized Choi Implanter Pen to extract and implant follicles simultaneously, reducing the time grafts spend outside the scalp and improving survival rates. The technique allows precise control over depth, angle, and direction of implanted hairs, producing extremely natural-looking hairlines.
DHI is the most labor-intensive and expensive surgical method, but graft survival rates can reach 95%+ in skilled hands. It is particularly effective for hairline design and areas requiring high density.
The ARTAS iX system and similar robotic platforms use computer vision, machine learning, and real-time image recognition to map the donor area, identify the healthiest multi-hair follicular units, calculate optimal extraction angles, and execute precise follicle harvesting with sub-millimeter accuracy.
In 2026, AI algorithms have advanced to adapt intraoperatively — adjusting to scalp responsiveness, hair curl patterns, and density variations in real time. Surgeons supervise and guide the system rather than manually extracting each graft, dramatically reducing fatigue and improving consistency across thousands of grafts.
Robotic systems now accommodate textured and curly hair types that were previously difficult to treat mechanically, expanding access across diverse patient populations.
PRP draws on the body's own healing system. A small sample of the patient's blood is drawn, spun in a centrifuge to concentrate the platelets and growth factors, then injected into the scalp at the follicle level. These growth factors stimulate dormant follicles, improve scalp circulation, and slow miniaturization.
In 2026, next-generation PRP protocols enhance the baseline formula with added peptides, micro-RNAs, and growth factor amplifiers — creating personalized concentrations calibrated to the patient's age, hair type, and specific loss pattern. PRP is FDA-recognized as safe for this application and is widely used both as a standalone treatment and as an adjunct to hair transplant surgery to improve graft survival.
Exosomes are nanoscale vesicles naturally secreted by stem cells. They carry proteins, growth factors, and signaling RNA that instruct other cells to regenerate, reduce inflammation, and stimulate new growth. When injected into the scalp, exosomes activate the Wnt/β-catenin pathway — the biological master switch for hair follicle regeneration.
Unlike PRP, which depends on the quality of the patient's own blood (which declines with age), lab-derived exosomes provide a standardized, high-potency dose of regenerative signals. In 2026, clinical studies combining exosome injections with microneedling have documented density gains of 30–35 hairs/cm² at the 12-month mark.
Important: No exosome products are currently FDA-approved for hair loss. Quality varies significantly across providers. Always verify clinic credentials and product sourcing before proceeding.
True stem cell therapy for hair restoration involves harnessing mesenchymal stem cells to regenerate damaged or dormant follicular structures. University of Virginia researchers confirmed in 2025 that hair follicle stem cells remain present even in bald scalp — making pattern loss theoretically reversible if these cells can be reactivated.
PP405 from Pelage Pharmaceuticals — which targets follicle stem cell reactivation — is currently entering Phase 3 clinical trials after 31% of patients in Phase 2a achieved 20%+ density increases. ET-02 from Eirion Therapeutics is in Phase 1. These treatments are not yet commercially available outside of registered clinical trials.
Warning: Many clinics market PRP or exosome treatments as "stem cell therapy." True stem cell transplantation is experimental and must be part of an IRB-approved clinical trial to be ethically and legally administered.
LLLT uses specific wavelengths of red and near-infrared light to stimulate cellular activity within hair follicles, improve scalp blood flow, and extend the anagen (growth) phase of the hair cycle. FDA-cleared devices are available both as in-clinic treatments and home-use devices (laser caps, helmets, combs).
LLLT works best for early-stage hair loss and as a complement to PRP, minoxidil, or post-transplant recovery. It is one of the few fully FDA-cleared modalities available for both men and women with no known side effects.
Minoxidil is the most widely used FDA-approved treatment for hair loss, available over the counter in topical form (2% for women, 5% for men) and by prescription in oral low-dose form. It extends the anagen growth phase of the hair cycle and improves blood flow to follicles.
Oral minoxidil (0.25–2.5mg daily) has gained significant clinical traction since 2022, showing strong results — including in women — with a more consistent absorption profile than topical application. It is used both as a standalone first-line treatment and as a maintenance protocol after transplant surgery.
Scalp Micropigmentation (SMP) is a specialized cosmetic tattooing technique that deposits pigment into the scalp to replicate the appearance of closely-shaved hair follicles. The result is the visual impression of a full, dense head of short hair — or added density to thinning areas — without any surgical procedure.
SMP delivers immediate, visible results and requires no recovery time. It is particularly effective for those not suitable for transplant surgery, those with extensive donor area depletion, or anyone seeking a confident, low-maintenance solution. Touch-ups are typically needed every 3–5 years.